STAT

OCTOBER 25, 2024

Earlier this month, the FDA declared an end to the shortage of Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, after almost two years. By law, that should have prohibited compound pharmacies from making copies of the drug, as they’re allowed to do so only when the treatment is on the shortage list. 

Compounding Pharmacies 284

Compounding Pharmacies Compounding Diabetes 284

STAT

NOVEMBER 6, 2024

… Novo Nordisk disclosed that it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded copies of its weight loss and diabetes drugs , Reuters writes. Given all the U.S. could inject themselves with a product that was not regulated, approved, or inspected.

Compounding 268

Compounding Compounding Pharmacies Diabetes Hospitals 268

STAT

OCTOBER 31, 2024

… All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available  on the U.S. With all doses now listed as available, the FDA may soon pull it off the list, depending on its conversations with Novo about whether the company can sufficiently meet demand going forward.

Compounding Pharmacies 266

Compounding Pharmacies Compounding Diabetes Packaging 266

BioPharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Compounding 122

Compounding Compounding Pharmacies Diabetes 122

STAT

SEPTEMBER 20, 2023

… As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity, STAT writes.

Compounding 249

Compounding Compounding Pharmacies Diabetes 249

STAT

OCTOBER 23, 2024

Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. … Novo Nordisk has asked the U.S.

Compounding 257

Compounding Compounding Pharmacies Biosimilars Documentation 257

STAT

SEPTEMBER 22, 2023

The techs who were queried identified chemotherapies; ADHD medicines; three drugs for weight loss and diabetes — Mounjaro, Ozempic, and Wegovy — and local anesthetics such as lidocaine as the top drugs experiencing shortages. And 72% said shortages very significantly or significantly impact their workflow.

Department of Veterans Affairs 273

Department of Veterans Affairs Pharmacy Technician Compounding Pharmacies Compounding 273

pharmaphorum

OCTOBER 14, 2024

Faced with lawsuit, FDA rethinks block on compounding pharmacies making Eli Lilly's diabetes and obesity drug tirzepatide

Compounding 110

Compounding Compounding Pharmacies Diabetes 110

pharmaphorum

OCTOBER 23, 2024

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

Compounding 116

Compounding Compounding Pharmacies Diabetes 116

STAT

DECEMBER 4, 2024

It mirrors results seen in the companies’ diabetes drugs, which use the same active ingredients.   A trade group for compounding pharmacies slammed an attempt by Novo Nordisk to convince the U.S.   A trade group for compounding pharmacies slammed an attempt by Novo Nordisk to convince the U.S.

Compounding 175

Compounding Compounding Pharmacies Diabetes Documentation 175

STAT

OCTOBER 8, 2024

… A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us.

Compounding 247

Compounding Compounding Pharmacies Vaccines Immunity 247

Compounding Pharmacy of America

DECEMBER 6, 2024

While many men experience occasional difficulties with sexual performance, persistent ED can be an early warning sign of serious underlying health issues such as cardiovascular disease, diabetes, or hormonal imbalances.

Compounding Pharmacies 98

Compounding Pharmacies Compounding Diabetes 98

Compounding Pharmacy of America

MARCH 29, 2024

An exploration of how proper diet, exercise, and a regiment of supplements combined with GLP-1 therapies can prevent and treat type 2 diabetes. The post The Role of GLP-1 Therapies in Type 2 Diabetes Prevention and Treatment appeared first on The Compounding Pharmacy of America.

Diabetes 59

Diabetes Compounding Pharmacies Compounding 59

STAT

OCTOBER 25, 2024

Earlier this month, the FDA declared an end to the shortage of Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, after almost two years. By law, that should have prohibited compounding pharmacies from making copies of the drug, as they are allowed to do so only when the treatment is on the shortage list.

Compounding 214

Compounding Compounding Pharmacies Diabetes Drug Development 214

Compounding Pharmacy of America

FEBRUARY 23, 2023

Many people need to address diabetes. So, how well does compounding diabetic medication address symptoms and one’s lifestyle? The post Supplements and Compounding Diabetic Medications appeared first on The Compounding Pharmacy of America.

Compounding 52

Compounding Diabetes Compounding Pharmacies 52

Welltopia Pharmacy

OCTOBER 17, 2024

A GLP-1 compounding pharmacy offers patients a customized, often more affordable alternative. Glucagon-like peptide-1 (GLP-1) receptor agonists have become essential in managing type 2 diabetes and aiding in weight loss.

Compounding Pharmacies 40

Compounding Pharmacies Compounding Diabetes 40

National Association of Boards of Pharmacy

DECEMBER 13, 2023

Injectable diabetes medications including semaglutide, namely Wegovy and Ozempic, have been in shortage since 2022 , limiting patient access to the drug across the nation. Simultaneously, compounding pharmacies have been overwhelmed with the production of semaglutide injections that are compounded copies of Ozempic and Wegovy.

Diabetes 56

Diabetes Compounding Pharmacies Compounding Online Pharmacies 56

Compounding Pharmacy of America

JULY 11, 2023

For those who are diabetic, there are vitamins, supplements, and compounding medications that can help you manage your condition. The post From A to Zinc: How Vitamins Help Manage Diabetes appeared first on The Compounding Pharmacy of America.

Diabetes 40

Diabetes Compounding Pharmacies Compounding 40

Compounding Pharmacy of America

AUGUST 24, 2022

When health professionals look in your mouth, your oral health can show symptoms of serious conditions like heart disease, diabetes and […]. appeared first on The Compounding Pharmacy of America. The post What Health Problems Are Related to Poor Oral Hygiene?

Compounding Pharmacies 52

Compounding Pharmacies Compounding Diabetes 52

Fusion Pharmacy

AUGUST 29, 2023

Hot Weight Loss Medications/Products That Have Recently Hit the Market Semaglutide, the active ingredient in brand-name drugs such as Ozempic, Wegovy, and Rybelsus, which were designed for the management of type 2 diabetes, have also been shown to be effective for weight loss.

Compounding Pharmacies 52

Compounding Pharmacies Compounding Diabetes 52

Quality Matters

OCTOBER 13, 2021

By enabling a multi-manufacturer environment, USP standards have helped increase the availability of medicines to treat cardiovascular disease, cancer, diabetes, mental health and many other conditions. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

The Thyroid Pharmacist

MAY 19, 2023

20] This medication is available only as a prescription and can be compounded into lower doses by special professional compounding pharmacies. National Institute of Diabetes and Digestive and Kidney Diseases. Lancet Diabetes Endocrinol. National Institute of Diabetes and Digestive and Kidney Diseases.

Immunity 93

Immunity Immunization Diabetes Compounding 93

The Physician Pharmacist

NOVEMBER 2, 2023

And we're utilizing direct to consumer genetic tests with a compounding pharmacy to custom compound, topical solutions for hair restoration. And because I, I could see things like a pharmacist, I can my pharmacy license is still active. And so me and my business partner, we started Nimbus healthcare.

Medical Schools 52

Medical Schools Compounding Hospitals Pharmacy Technician 52

The Thyroid Pharmacist

NOVEMBER 15, 2024

There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.

Diabetes 71

Diabetes Immunity Immunization Compounding 71